rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2000-5-19
|
pubmed:abstractText |
It has been shown previously that the internal mammary artery releases more cyclic guanosine monophosphate after stimulation with atrial natriuretic peptide than the saphenous vein, and that C-type natriuretic peptide possesses a cyclic guanosine monophosphate stimulating potential on saphenous vein bypass grafts. The present study was undertaken to investigate intracellular content and extracellular release of cyclic guanosine monophosphate, by the internal mammary artery and saphenous vein, after challenge with further members of the natriuretic peptide family.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1010-7940
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
175-81
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
|
pubmed:year |
2000
|
pubmed:articleTitle |
Natriuretic peptides stimulate cyclic guanosine monophosphate production in human saphenous vein and internal mammary artery.
|
pubmed:affiliation |
Division of Surgery/Cardiac Surgery, Innsbruck University Hospital, University of Innsbruck, Innsbruck, Austria. johannes.o.bonatti@uibk.ac.at
|
pubmed:publicationType |
Journal Article,
Comparative Study,
In Vitro
|